Stay updated on Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:17:25.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T17:36:08.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T17:14:22.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T18:08:38.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the usual study record content, indicating the page is currently inaccessible. The rendered page displays a generic error layout rather than the study details.
    Difference
    17%
    Check dated 2026-09-19T22:06:35.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a page revision or software update. This change does not modify the study details or other substantive content on the page.
    Difference
    0.0%
    Check dated 2026-08-29T18:32:55.000Z thumbnail image

Stay in the know with updates to Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.